Summary

Germany Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026

Summary

Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The German biotechnology market had total revenues of $27.2 billion in 2021, representing a compound annual growth rate (CAGR) of 24% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $13.5 billion, equivalent to 49.7% of the market's overall value.
- The successful performance of the German market has historically been fueled by a strong private and public financial backing, a trend which has been accelerated in 2020 and 2021 as the COVID-19 pandemic has attracted significant investment in the global race to develop effective solutions to control the outbreak and protect citizens.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts

Reasons to Buy

- What was the size of the Germany biotechnology market by value in 2021?
- What will be the size of the Germany biotechnology market in 2026?
- What factors are affecting the strength of competition in the Germany biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Germany's biotechnology market?

ページTOPに戻る

Table of Contents

Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
8 Company Profiles
8.1. Bayer AG
8.2. Boehringer Ingelheim GmbH
8.3. BioNTech SE
8.4. Merck & Co., Inc.
8.5. MorphoSys AG
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine